Current as at 28 November 2017

Australia conducts an aggressive vaccination program – far more aggressive than many nations in the world.  By the time a child is five, s/he will have received a total of 41 vaccine doses when the schedule has been followed to the letter.  This rises to 46 vaccine doses when the recommended yearly influenza vaccines are included, and then to 50 doses when the two recommended antenatal vaccines, Influenza, Diphtheria, Tetanus and Whooping Cough are also included.

See 1975 and 1996 schedules further down the page, for comparison.

National Immunisation Program Schedule   (click to visit website)

Standard Schedule

School Vaccination Programs

At-risk groups

Other at-risk groups

———————————————————————————————————————————

1975

For comparison, below is Australia’s vaccination schedule for 1975.

You can see that in 1975, children were given 18 vaccine doses up to the age of 6 years. Vaccination started at 3 months of age, and children were not given more than 3 doses at a time.

In 2016 there are 41 vaccine doses given, and when you include the Influenza vaccine (which is recommended annually for all children over the age of 6 mths) it reaches 46 vaccine doses for children up to the age of five years, and they are vaccinated for up to 8 diseases at a time.

Recommended schedule of basic immunisation, Australia 1975.

Smallpox: The optimum age of primary vaccination against smallpox is between one and four years.

Australian Government Publishing Service
Canberra 1975

1996

Here is the 1996 schedule, also for comparison:

Australian Standard Vaccination Schedule 1996

DTPw is the abbreviation for Diphtheria-Tetanus-whole cell Pertussis vaccine.
** Abbreviations for Hib vaccines – HbOC is ‘HibTITER’, PRP-OMP is ‘PedvaxHIB’.

———————————————————————————————————————————

Is the general health of our children worsening rather than improving? Autoimmune and neurological disorders have been increasing significantly from the 1990’s to now. Why is this?

“For the first time in over a decade the federal government is releasing new data on the number of children with developmental disabilities, reporting that diagnoses have grown significantly since the 1990s.
About 1 in 6 U.S. children are diagnosed with a developmental disability, according to a new Centers for Disease Control and Prevention study published online in the journal Pediatrics Monday. That represents an increase of 17 percent between 1997 and 2008 alone.”
http://www.disabilityscoop.com/2011/05/23/cdc-1-in-6/13146/

—————————————–

“Key findings. In 2007, approximately 3 million children under age 18 years (3.9%) were reported to have a food or digestive allergy in the previous 12 months.
From 1997 to 2007, the prevalence of reported food allergy increased 18% among children under age 18 years. Children with food allergy are two to four times more likely to have other related conditions such as asthma and other allergies, compared with children without food allergies.
From 2004 to 2006, there were approximately 9,500 hospital discharges per year with a diagnosis related to food allergy among children under age 18 years.
Note: See Definitions for an explanation of reported food allergy.
Food allergy is a potentially serious immune response to eating specific foods or food additives. Eight types of food account for over 90% of allergic reactions in affected individuals: milk, eggs, peanuts, tree nuts, fish, shellfish, soy, and wheat (1,2). Reactions to these foods by an allergic person can range from a tingling sensation around the mouth and lips and hives to death, depending on the severity of the allergy. The mechanisms by which a person develops an allergy to specific foods are largely unknown. Food allergy is more prevalent in children than adults, and a majority of affected children will “outgrow food” allergies with age. However, food allergy can sometimes become a lifelong concern (1). Food allergies can greatly affect children and their families’ well-being. There are some indications that the prevalence of food allergy may be increasing in the United States and in other countries (2-4).”
http://www.cdc.gov/nchs/data/databriefs/db10.htm

—————————————–
“RESULTS:
An estimated 43% of US children (32 million) currently have at least 1 of 20 chronic health conditions assessed, increasing to 54.1% when overweight, obesity, or being at risk for developmental delays are included; 19.2% (14.2 million) have conditions resulting in a special health care need, a 1.6 point increase since 2003.”
http://www.ncbi.nlm.nih.gov/pubmed/21570014

—————————————–

Adjuvants and autoimmunity

Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations.
“Abstract
Immune challenges during early development, including those vaccine-induced, can lead to permanent detrimental alterations of the brain and immune function. Experimental evidence also shows that simultaneous administration of as little as two to three immune adjuvants can overcome genetic resistance to autoimmunity. In some developed countries, by the time children are 4 to 6 years old, they will have received a total of 126 antigenic compounds along with high amounts of aluminum (Al) adjuvants through routine vaccinations. According to the US Food and Drug Administration, safety assessments for vaccines have often not included appropriate toxicity studies because vaccines have not been viewed as inherently toxic. Taken together, these observations raise plausible concerns about the overall safety of current childhood vaccination programs. When assessing adjuvant toxicity in children, several key points ought to be considered: (i) infants and children should not be viewed as “small adults” with regard to toxicological risk as their unique physiology makes them much more vulnerable to toxic insults; (ii) in adult humans Al vaccine adjuvants have been linked to a variety of serious autoimmune and inflammatory conditions (i.e., “ASIA”), yet children are regularly exposed to much higher amounts of Al from vaccines than adults; (iii) it is often assumed that peripheral immune responses do not affect brain function. However, it is now clearly established that there is a bidirectional neuro-immune cross-talk that plays crucial roles in immunoregulation as well as brain function. In turn, perturbations of the neuro-immune axis have been demonstrated in many autoimmune diseases encompassed in “ASIA” and are thought to be driven by a hyperactive immune response; and (iv) the same components of the neuro-immune axis that play key roles in brain development and immune function are heavily targeted by Al adjuvants. In summary, research evidence shows that increasing concerns about current vaccination practices may indeed be warranted. Because children may be most at risk of vaccine-induced complications, a rigorous evaluation of the vaccine-related adverse health impacts in the pediatric population is urgently needed.”
http://www.ncbi.nlm.nih.gov/pubmed/22235057

“Alongside their supportive role, adjuvants were found to inflict by themselves an illness of autoimmune nature, defined as ‘the adjuvant diseases’. The debatable question of silicone as an adjuvant and connective tissue diseases, as well as the Gulf War syndrome and macrophagic myofaciitis which followed multiple injections of aluminium-based vaccines, are presented here. Owing to the adverse effects exerted by adjuvants, there is no doubt that safer adjuvants need to be developed and incorporated into future vaccines.”
http://lup.sagepub.com/content/18/13/1217.short